Free Trial
→ No. 1 stock to cash in on the death of iPhone (From Stansberry Research) (Ad)tc pixel
NASDAQ:AQB

AquaBounty Technologies Q2 2025 Earnings Results & Report

AquaBounty Technologies logo
$1.05 +0.08 (+7.78%)
As of 10/9/2026 04:00 PM Eastern

AquaBounty Technologies missed analyst earnings expectations in its Q2 2025 results, released August 5, 2025. The company reported EPS of -$0.63 versus the -$0.53 consensus estimate.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens

AquaBounty Technologies EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.53
Beat/Miss
Missed by -$0.10
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 8 quarters

AquaBounty Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.50 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

AquaBounty Technologies' next earnings date is estimated for Tuesday, November 10, 2026, based on past reporting schedules.

Conference Call Resources

AquaBounty Technologies Q2 2025 Earnings FAQ

AquaBounty Technologies (NASDAQ:AQB) reported earnings of -$0.63 per share for Q2 2025, missing the consensus estimate of -$0.53. The report was announced on Tuesday, August 5, 2025.

AquaBounty Technologies' next earnings date is estimated for Tuesday, November 10, 2026. MarketBeat tracks confirmed and estimated earnings dates for AquaBounty Technologies on the company's earnings history page.

AquaBounty Technologies Earnings Headlines

AquaBounty Technologies, Inc.: AquaBounty Announces Engagement of Colliers as Exclusive Agent for its Ohio Property
September 15, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-09/69584636-aquabounty-technologies-inc-aquabounty-announces-engagement-of-colliers-as-exclusive-agent-for-its-ohio-property-296.htm
AquaBounty Raises Capital Through Preferred Stock Offering
June 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/aquabounty-raises-capital-through-preferred-stock-offering?utm_source=marketbeat.com&utm_medium=referral
This high yielding “gold annuity” is starting to move…
Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields up 1,298%, Reunion Gold up 716%, and Highlander Silver up 741%. Now he has released a new research report on a unique high yielding gold security backed by what he calls the world's best gold mine today, offering a yield now plus long term upside.tc pixel
October 10 at 1:00 AM  |  Golden Portfolio (Ad)
AquaBounty Shareholders Approve Proposals, Reverse Split Authority
June 25, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/aquabounty-shareholders-approve-proposals-reverse-split-authority?utm_source=marketbeat.com&utm_medium=referral
AquaBounty Technologies Inc.
April 17, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/aqb/company-people
AquaBounty Undertakes Debt Exchange and Preferred Stock Financing
April 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/aquabounty-undertakes-debt-exchange-and-preferred-stock-financing?utm_source=marketbeat.com&utm_medium=referral
See More AquaBounty Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AquaBounty Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AquaBounty Technologies and other key companies, straight to your email.

About AquaBounty Technologies

AquaBounty Technologies (NASDAQ:AQB) is a biotechnology and aquaculture company focused on developing land-based, land-based recirculating aquaculture systems (RAS) to produce Atlantic salmon. The company’s approach is designed to support year-round fish production while reducing reliance on ocean-based farming and limiting water use through treatment and reuse.

AquaBounty’s principal product is AquAdvantage salmon, a genetically engineered Atlantic salmon developed to reach market size more efficiently than conventional Atlantic salmon. The product received approval from the U.S. Food and Drug Administration for production, sale and consumption in the United States in 2020, following earlier regulatory approvals related to its production process. AquaBounty has also developed expertise in salmon breeding, hatchery operations and RAS technology.

The company has historically pursued production activities in North America and has operated or developed facilities in the United States and Canada, while its salmon production model has also involved international operations and partnerships. AquaBounty is headquartered in the United States and trades on the Nasdaq under the symbol AQB.

View AquaBounty Technologies Profile
Earnings Tools